December 20, 2018
Tag: Leukemia Clinical Program
![A newly-married bride and groom exit their wedding reception through a tunnel of friends and family holding sparklers.](https://unclineberger.org/wp-content/uploads/sites/867/2018/11/a-cancer-diagnosis-changed-their-wedding-plans-image2.jpeg)
November 8, 2018
A cancer diagnosis changed their wedding plans, but strengthened their bond
A diagnosis with a rare type of blood cancer called acute promyelocytic leukemia just days before his wedding influenced Dustin Riedesel's perspective on marriage, and inspired him and his now-wife, Katie, to raise money to support cancer research.
![W. G. Champion “Champ” and Etteinne “ET” Mitchell of New Bern, North Carolina, made a $10 million donation to UNC Lineberger Comprehensive Cancer Center to support ground-breaking research in blood cancer,including lymphoma, leukemia and myeloma research.](https://unclineberger.org/wp-content/uploads/sites/867/2018/11/mitchells-donate-10-million-to-further-blood-cancer-research-image2-600x400.jpeg)
October 29, 2018
Former patient donates $10 million to further blood cancer research at UNC Lineberger
Etteinne “ET” and W. G. Champion “Champ” Mitchell of New Bern, North Carolina, will create a new fund supporting ground-breaking research in blood cancer at UNC Lineberger Comprehensive Cancer Center, including lymphoma, leukemia and myeloma research, in gratitude for the care Champ received and to bolster research directed at finding cures.
![A study led by Ben Vincent, MD, (left) and Paul Armistead, MD, PhD, could aid in the development of immune-based treatments that are tailored to individual leukemia patients who are undergoing stem cell transplantation.](https://unclineberger.org/wp-content/uploads/sites/867/2018/10/immune-based-leukemia-treatments-image2-600x400.jpeg)
August 29, 2018
Researchers lay the foundation for personalized immune treatments for leukemia
In the journal Blood Advances, UNC Lineberger’s Ben Vincent, MD, Paul Armistead, MD, PhD, and their collaborators reported early findings from a new study that could aid in the development of immune-based treatments that are tailored to individual leukemia patients who are undergoing stem cell transplantation.
![UNC Lineberger's Greg Wang, PhD.](https://unclineberger.org/wp-content/uploads/sites/867/2018/10/researchers-define-structure-function-image2-600x400.jpeg)
February 13, 2018
Researchers define structure, function of enzyme key to blood cancers
In the journal Nature, UNC Lineberger's Greg Wang, PhD, and colleagues reported findings about the structure and function of the DNMT3A enzyme complex, which helps control gene expression.
![William A. Wood, MD, is a UNC Lineberger member and associate professor in the UNC School of Medicine Division of Hematology and Oncology.](https://unclineberger.org/wp-content/uploads/sites/867/2018/10/risk-of-death-from-blood-cancer-image2-600x400.jpeg)
June 28, 2016
Risk of death for adults with blood cancer higher in three N.C. regions
UNC Lineberger researchers led by Dr. William A. Wood found that for patients treated in a hospital, the risk of death from acute myeloid leukemia was elevated in three regions of the state compared to a benchmark.
![Credit: Amanda Chang. G. Greg Wang, PhD, is a UNC Lineberger member and an assistant professor in the UNC School of Medicine Department of Biochemistry and Biophysics.](https://unclineberger.org/wp-content/uploads/sites/867/2018/10/faulty-instructions-image2-600x400.jpeg)
June 23, 2016
Researchers discover how faulty genetic instructions drive a deadly blood cancer in adults
A study by UNC Lineberger researcher G. Greg Wang, PhD, and colleagues uncovered the genetic mechanism behind how acute myeloid leukemia cells with a specific DNA mutation stay as undifferentiated cells, rather than maturing into healthy blood cells.
![](https://unclineberger.org/wp-content/uploads/sites/867/2018/10/unc-lineberger-team-finds-possible-strategy-to-overcome-radiation-therapy-resistance-acquired-by-cancer-cells-image2-600x400.jpeg)
June 25, 2015
UNC Lineberger team finds possible strategy to overcome radiation therapy resistance acquired by cancer cells
In a new study published in the Cell Press journal Chemistry & Biology, researchers share a discovery that they say could lead to a new strategy for sensitizing radiation-resistant cancer cells to the treatment.
![Veatrice Harris calls her team of caregivers her “UNC family.” (L to R) Monique Clayton, RN, BSN, clinical trials study coordinator; Veatrice Harris; her husband Jonathan Harris; and Jack Zhang, RN, BSN, clinical trials study coordinator.](https://unclineberger.org/wp-content/uploads/sites/867/2018/10/veatrice-harris-image2-600x400.jpeg)
June 23, 2015
Veatrice Harris
Veatrice Harris wasn’t afraid of battling cancer. She leaned on her faith, her family, and her UNC caregivers to face the toughest year of her life. Now, thanks to an innovative procedure called a 50/50 bone marrow transplant, Veatrice has renewed hope for 2015.
![](https://unclineberger.org/wp-content/uploads/sites/867/2018/10/sylvia-hatchell-image2-454x400.jpeg)
March 20, 2015
Sylvia Hatchell
“You don’t have the choice that you have cancer," says UNC Women's Basketball Coach and leukemia survivor Sylvia Hatchell. "But you have the choice in how you deal with it.”